Krisztina Larson, M.D. Joins The Oncology Institute of Hope and Innovation

Wednesday, August 14, 2019 General News
Email Print This Page Comment bookmark
Font : A-A+

The Oncology Institute of Hope and Innovation welcomes Krisztina Larson M.D., to their team of specialists.

CERRITOS, Calif., Aug. 14, 2019 /PRNewswire-PRWeb/ -- Dr. Krisztina Larson is a graduate

of Semmelweis University Faculty of Medicine in Budapest, Hungary. She completed her Internship and Residency from the University of Mississippi Medical Center in Jackson, Mississippi and her Hematology and Oncology Fellowship at LSU Health Sciences Center, Shreveport, Louisiana. She is fluent in Hungarian and Spanish and knows basic Hebrew.

Membership and Societies

American College of Physicians American Society of Hematology American Society of Clinical Oncology

Patient Care Philosophy

Dr. Larson understands the importance of giving the best individual care for each of her patients. She strives to educate and communicate fluidly with her patients and their families. She enjoys getting to know her patients and their families. She remains active in research and clinical studies.

About The Oncology Institute

Founded in 2007, The Oncology Institute of Hope and Innovation is dedicated to excelling in cancer prevention, diagnosis, and education. As the largest private practice cancer center in California, The Oncology Institute continues to provide extensive services including state-of-the-art infusion centers, chemotherapy educational sessions, in-house support groups, dietary and nutritional counseling, in-house pharmacy, financial counseling, clinical trials, comprehensive lab testing, and end of life counseling. They also offer support programs to help patients and families cope with the challenges brought on by cancer. Today, the Oncology Institute has served over 100,000 patients throughout 28 locations in Southern California, 5 in Arizona and 2 in Nevada.

 

SOURCE The Foundation of Hope and Innovation



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store